Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

ALI GUERMAZI

Allopathic & Osteopathic Physicians Radiology Diagnostic Radiology

NPI
1275661357
CMS profile
148368
Location
WEST ROXBURY, MA

General Payments · PY2019–2025

$1,774,163.50

  • Reported across 309 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$101,168.62

26 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $100,025.00 21
Travel and Lodging $970.34 4
Food and Beverage $173.28 1

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Pacira Pharmaceuticals Incorporated $81,393.62 20
Genmab U.S., Inc. $10,250.00 2
GlaxoSmithKline, LLC. $6,400.00 3
ARGENX US, INC. $3,125.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $547,414.49 106
PY2020 $277,048.12 88
PY2021 $755,670.00 46
PY2022 $15,460.00 12
PY2023 $23,078.22 13
PY2024 $54,324.05 18
PY2025 $101,168.62 26

Payment records · PY2025 (26)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ARGENX US, INC. $3,125.00 03/21/2025 Consulting Fee Undisputed 06/30/2026 1240422163 CMS
Genmab U.S., Inc. $4,250.00 01/23/2025 Consulting Fee Undisputed 06/30/2026 1235917802 CMS
Genmab U.S., Inc. $6,000.00 09/25/2025 Consulting Fee Undisputed 06/30/2026 1235917804 CMS
GlaxoSmithKline, LLC. $1,600.00 06/19/2025 Consulting Fee Undisputed 06/30/2026 1190942689 CMS
GlaxoSmithKline, LLC. $2,400.00 08/21/2025 Consulting Fee Undisputed 06/30/2026 1190397836 CMS
GlaxoSmithKline, LLC. $2,400.00 09/17/2025 Consulting Fee Undisputed 06/30/2026 1191047027 CMS
Pacira Pharmaceuticals Incorporated $1,530.00 03/18/2025 Consulting Fee Undisputed 06/30/2026 1250265317 CMS
Pacira Pharmaceuticals Incorporated $508.96 05/06/2025 Travel and Lodging Undisputed 06/30/2026 1250265311 CMS
Pacira Pharmaceuticals Incorporated $4,845.00 05/06/2025 Consulting Fee Undisputed 06/30/2026 1250265319 CMS
Pacira Pharmaceuticals Incorporated $219.38 05/16/2025 Travel and Lodging Undisputed 06/30/2026 1250265309 CMS
Pacira Pharmaceuticals Incorporated $200.00 05/16/2025 Travel and Lodging Undisputed 06/30/2026 1250265313 CMS
Pacira Pharmaceuticals Incorporated $173.28 05/17/2025 Food and Beverage Undisputed 06/30/2026 1250265307 CMS
Pacira Pharmaceuticals Incorporated $42.00 05/17/2025 Travel and Lodging Undisputed 06/30/2026 1250265315 CMS
Pacira Pharmaceuticals Incorporated $2,550.00 06/12/2025 Consulting Fee Undisputed 06/30/2026 1250265321 CMS
Pacira Pharmaceuticals Incorporated $5,610.00 06/12/2025 Consulting Fee Undisputed 06/30/2026 1250265323 CMS
Pacira Pharmaceuticals Incorporated $765.00 07/22/2025 Consulting Fee Undisputed 06/30/2026 1250265325 CMS
Pacira Pharmaceuticals Incorporated $8,415.00 09/23/2025 Consulting Fee Undisputed 06/30/2026 1250265327 CMS
Pacira Pharmaceuticals Incorporated $8,260.00 10/14/2025 Consulting Fee Undisputed 06/30/2026 1250265293 CMS
Pacira Pharmaceuticals Incorporated $15,710.00 10/14/2025 Consulting Fee Undisputed 06/30/2026 1250265299 CMS
Pacira Pharmaceuticals Incorporated $7,650.00 11/06/2025 Consulting Fee Undisputed 06/30/2026 1250265291 CMS
Pacira Pharmaceuticals Incorporated $255.00 11/06/2025 Consulting Fee Undisputed 06/30/2026 1250265295 CMS
Pacira Pharmaceuticals Incorporated $12,225.00 11/20/2025 Consulting Fee Undisputed 06/30/2026 1250265297 CMS
Pacira Pharmaceuticals Incorporated $510.00 11/25/2025 Consulting Fee Undisputed 06/30/2026 1250265329 CMS
Pacira Pharmaceuticals Incorporated $2,080.00 12/11/2025 Consulting Fee Undisputed 06/30/2026 1250265301 CMS
Pacira Pharmaceuticals Incorporated $4,845.00 12/22/2025 Consulting Fee Undisputed 06/30/2026 1250265303 CMS
Pacira Pharmaceuticals Incorporated $5,000.00 12/22/2025 Consulting Fee Undisputed 06/30/2026 1250265305 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.